NIP7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.384800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.782800E-01
Normal-vs-Stage2
4.711400E-01
Normal-vs-Stage3
4.431200E-01
Normal-vs-Stage4
1.760470E-02
Stage1-vs-Stage2
3.325000E-01
Stage1-vs-Stage3
4.916600E-01
Stage1-vs-Stage4
2.171800E-02
Stage2-vs-Stage3
1.204600E-01
Stage2-vs-Stage4
2.980100E-02
Stage3-vs-Stage4
9.240700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.428600E-01
Normal-vs-AfricanAmerican
3.972600E-01
Normal-vs-Asian
9.235200E-01
Caucasian-vs-AfricanAmerican
6.086600E-01
Caucasian-vs-Asian
2.052000E-01
AfricanAmerican-vs-Asian
1.456950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.773200E-01
Normal-vs-Female
4.870800E-01
Male-vs-Female
8.466800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.881600E-01
Normal-vs-Age(41-60Yrs)
3.477800E-01
Normal-vs-Age(61-80Yrs)
6.575200E-01
Normal-vs-Age(81-100Yrs)
4.029800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.515200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.477800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.219800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.299010E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.764600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.748800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.368800E-01
Normal-vs-Daily Drinker
8.167600E-01
Normal-vs-Weekly Drinker
6.818000E-01
Normal-vs-Occasional Drinker
1.700970E-01
Normal-vs-Social Drinker
6.356200E-01
Non Drinker-vs-Daily Drinker
9.620400E-01
Non Drinker-vs-Weekly Drinker
7.363400E-01
Non Drinker-vs-Occasional Drinker
3.427600E-02
Non Drinker-vs-Social Drinker
7.072000E-01
Daily Drinker-vs-Weekly Drinker
7.624400E-01
Daily Drinker-vs-Occasional Drinker
8.486100E-02
Daily Drinker-vs-Social Drinker
7.384400E-01
Weekly Drinker-vs-Occasional Drinker
1.965640E-01
Weekly Drinker-vs-Social Drinker
9.922200E-01
Occasional Drinker-vs-Social Drinker
1.638400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.209200E-01
Normal-vs-Grade 2
7.126200E-02
Normal-vs-Grade 3
9.250400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.090400E-02
Grade 1-vs-Grade 3
4.315600E-03
Grade 1-vs-Grade 4
5.209200E-01
Grade 2-vs-Grade 3
2.342800E-01
Grade 2-vs-Grade 4
7.126200E-02
Grade 3-vs-Grade 4
9.250400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.136800E-01
Normal-vs-NonDiabetic
5.980400E-01
Diabetic-vs-NonDiabetic
7.189000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.634200E-01
Normal-vs-NoPancreatitis
5.797400E-01
Pancreatitis-vs-NoPancreatitis
3.085600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.651200E-01
Normal-vs-N1
4.451000E-01
N0-vs-N1
2.001800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.600040E-03
Normal-vs-TP53-NonMutant
9.085600E-01
TP53-Mutant-vs-TP53-NonMutant
1.50794000000065E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
